Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-18 06:19 am Purchase | 2025-02-11 | 13G | Lixte Biotechnology Holdings, Inc. LIXT | Mitchell P. Kopin | 138,763 4.990% | 138,763 (New Position) | Filing History |
| 2025-02-11 4:53 pm Purchase | 2025-02-05 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Mitchell P. Kopin | 386,792 4.990% | 102,242 (+35.93%) | Filing History |
| 2025-02-11 4:51 pm Purchase | 2025-02-05 | 13G | Mustang Bio, Inc. MBIO | Mitchell P. Kopin | 186,552 9.990% | 186,552 (New Position) | Filing History |
| 2025-02-05 5:15 pm Purchase | 2025-01-30 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 103,951 4.990% | 103,951 (New Position) | Filing History |
| 2025-02-05 5:13 pm Purchase | 2025-01-30 | 13G | SaverOne 2014 Ltd SVRE | Mitchell P. Kopin | 35,459,516 4.990% | 35,459,516 (New Position) | Filing History |
| 2025-02-03 4:05 pm Purchase | 2025-01-28 | 13G | 60 Degrees Pharmaceuticals, Inc. SXTP | Mitchell P. Kopin | 284,550 4.990% | 284,550 (New Position) | Filing History |
| 2025-01-28 5:25 pm Purchase | 2025-01-23 | 13G | Dermata Therapeutics, Inc. DRMA | Mitchell P. Kopin | 262,468 6.700% | 262,468 (New Position) | Filing History |
| 2025-01-27 06:14 am Purchase | 2025-01-21 | 13G | Color Star Technology Co., Ltd. ADD | Mitchell P. Kopin | 504,488 9.990% | 504,488 (New Position) | Filing History |
| 2025-01-21 5:49 pm Purchase | 2025-01-15 | 13G | Biomotion Sciences Ordinary Shares SLXN | Mitchell P. Kopin | 209,827 4.990% | 209,827 (New Position) | Filing History |
| 2025-01-17 4:44 pm Purchase | 2025-01-13 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 530,171 9.990% | 439,184 (+482.69%) | Filing History |
| 2025-01-16 6:34 pm Purchase | 2025-01-12 | 13G | NAYA Biosciences, Inc. NAYA | Mitchell P. Kopin | 504,478 6.900% | 320,478 (+174.17%) | Filing History |
| 2025-01-15 4:03 pm Purchase | 2024-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 714,844 9.990% | 714,844 (New Position) | Filing History |
| 2025-01-14 5:49 pm Purchase | 2025-01-07 | 13G | ReWalk Robotics Ltd. LFWD | Mitchell P. Kopin | 553,821 4.990% | 213,067 (+62.53%) | Filing History |
| 2025-01-14 5:45 pm Unchanged | 2025-01-08 | 13G | DatChat, Inc. DATS | Mitchell P. Kopin | 0 0.000% | 0 (Unchanged) | Filing History |
| 2025-01-10 6:53 pm Purchase | 2025-01-06 | 13G | Microbot Medical Inc. MBOT | Mitchell P. Kopin | 2,672,084 8.800% | 2,672,084 (New Position) | Filing History |
| 2025-01-10 6:51 pm Purchase | 2025-01-06 | 13G | BioLineRx Ltd. BLRX | Mitchell P. Kopin | 2,555,903 4.990% | 2,077,581 (+434.35%) | Filing History |
| 2025-01-03 8:08 pm Purchase | 2024-12-27 | 13G | 180 Life Sciences Corp. ATNF | Mitchell P. Kopin | 165,293 4.990% | 165,293 (New Position) | Filing History |
| 2025-01-03 8:04 pm Purchase | 2024-12-26 | 13G | Gaxos.ai Inc. GXAI | Mitchell P. Kopin | 363,625 4.990% | 70,728 (+24.15%) | Filing History |
| 2024-12-30 5:39 pm Purchase | 2024-12-22 | 13G | Vivos Therapeutics, Inc. VVOS | Mitchell P. Kopin | 297,315 4.990% | 297,315 (New Position) | Filing History |
| 2024-12-27 5:05 pm Purchase | 2024-12-19 | 13G | Phio Pharmaceuticals Corp. PHIO | Mitchell P. Kopin | 90,987 4.990% | 45,782 (+101.28%) | Filing History |